You are here

Jakafi

With Jakafi's patent cliff looming, Incyte looks to 2025 launches to bulk up revenue by decade's end

Fierce Pharma

Wed, 10/30/24 - 11:42 am

graft vs host disease

follicular lymphoma

squamous cell anal carcinoma

Blood cancer trial finds ruxolitinib better than current treatments

Clinical Trials Arena

Fri, 05/5/23 - 10:13 am

clinical trials

polycythemia vera

Incyte Abandons Phase III Trial for Myelofibrosis Treatment

BioSpace

Mon, 03/6/23 - 11:06 am

clinical trials

Incyte on a Roll with Two FDA Wins in Two Days

BioSpace

Thu, 09/23/21 - 10:55 pm

graft vs host disease

atopic dermatitis

Incyte to pay $12.6 million to resolve drug charity kickback claims

Reuters

Fri, 05/7/21 - 10:54 am

Incyte Drug Misses Endpoint in COVID-Respiratory-Distress Trial

TheStreet.com

Sun, 03/21/21 - 11:57 pm

clinical trials

Jakafi failed the primary endpoint in a Covid-19 study. But Incyte is still going to FDA with a compassionate use pitch

Endpoints

Fri, 03/19/21 - 10:49 am

clinical trials

FDA to quickly review Incyte’s Jakafi in chronic GVHD

Pharmaforum

Tue, 02/23/21 - 10:42 am

graft vs host disease

Novartis/Incyte draw blank with Jakafi in COVID-19

Pharmaforum

Mon, 12/14/20 - 10:35 am

clinical trials

Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win

Fierce Pharma

Wed, 04/22/20 - 10:45 pm

clinical trials

graft vs host disease

Incyte, Novartis launch drug study to treat coronavirus complication

Marketwatch

Sat, 04/18/20 - 11:22 pm

clinical trials

Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19

Motley Fool

Fri, 04/3/20 - 12:02 am

Can Jakafi hit $3B? Incyte thinks so—and it's got other launches on the way

Fierce Pharma

Thu, 02/13/20 - 11:28 pm

Is IBD 50 Drugmaker Incyte Stock On The Cusp Of Innovation-Fueled Growth Spurt?

Investors Business Daily

Tue, 12/3/19 - 09:47 am

Incyte's cash cow Jakafi chugs along with positive frontline results for GVHD

Endpoints

Wed, 10/16/19 - 12:23 pm

graft vs host disease

This Could Be a Big Year for Incyte

Motley Fool

Wed, 09/18/19 - 06:52 pm

Incyte (INCY) Receives FDA Nod for Label Expansion of Jakafi

Yahoo/Zacks.com

Tue, 05/28/19 - 10:07 am

graft vs host disease

Incyte Down as FDA Extends Review Period of Jakafi for GVHD

Yahoo/Zacks.com

Sat, 02/9/19 - 12:23 pm

graft vs host disease

FDA Grants Priority Review for Ruxolitinib (Jakafi) for Acute Graft-Versus-Host Disease

CP Wire

Thu, 10/25/18 - 09:52 am

graft vs host disease

FDA Grants Priority Review for Ruxolitinib (Jakafi) for Acute Graft-Versus-Host Disease

Thu, 10/25/18 - 09:35 am

graft vs host disease

Pages